Allot

Allot Ltd, founded in 2010 and headquartered in the UK, specializes in data-driven solutions for the pharmaceutical and healthcare sectors.

Reviewed by 7wData
Share Email

On this page

Profile

Allot provides data-driven tools and services to help pharmaceutical companies optimize their commercial strategies.

Allot Ltd, founded in 2010 and headquartered in the UK, specializes in data-driven solutions for the pharmaceutical and healthcare sectors. The company provides tools and services that help pharmaceutical companies optimize their commercial strategies, particularly in navigating complex healthcare systems like the NHS. Allot’s flagship products include Pharlytics®, which tracks drug formulary and prescribing guidance status, and RankX©, a scoring tool for evaluating healthcare professionals and organizations.

The company also offers commercial data services, filling gaps in pharmaceutical industry information to support market expansion and competitive analysis. Allot has carved out a niche in the UK market, focusing on providing actionable insights that enable pharmaceutical companies to align their strategies with NHS guidance and formulary reviews. While the company has not disclosed recent financials, its focus on generative AI and sustainability services indicates a strategic pivot towards emerging technologies and ESG compliance.

Allot’s blog highlights its ongoing efforts to integrate AI into commercial pharma, suggesting a forward-looking approach to industry challenges. However, the company operates in a highly competitive and regulated market, where shifts in healthcare policy and data privacy concerns could impact its growth trajectory.

Track Allot and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Pharmaceutical companies
  • Biotech firms
  • Healthcare organizations
  • Market research firms
  • Sustainability-focused enterprises

Strengths and what to watch

Strengths

  • Specialized expertise in NHS formulary and prescribing guidance
  • Proprietary tools like Pharlytics® and RankX© for data-driven decision-making
  • Focus on integrating generative AI into commercial pharma strategies

Watch for

  • High dependency on NHS policies and regulations
  • Competition from larger data analytics firms
  • Potential challenges in scaling sustainability and AI services

Key Information

Founded
2010
Headquarters
UK

Frequently Asked Questions

What does Allot do for pharmaceutical companies?

Allot provides data-driven tools like Pharlytics® for tracking drug formulary status and RankX© for scoring healthcare professionals. These help pharma firms optimize commercial strategies, particularly for NHS markets. The company focuses on actionable insights, AI integration, and sustainability services for better decision-making. (47 words)

How does Pharlytics help with NHS drug formularies?

Pharlytics® tracks prescription drug status across NHS formularies and updates prescribing guidance changes. This gives pharmaceutical companies real-time visibility into formulary placements, helping them align product strategies with NHS policies and identify market opportunities more effectively. (42 words)

What makes RankX useful for pharma sales teams?

RankX© scores healthcare professionals and organizations based on prescribing behaviors and influence. These data-driven evaluations help pharma commercial teams prioritize engagements, tailor messaging, and allocate resources efficiently within complex healthcare systems like the NHS. (44 words)

Is Allot using AI for pharmaceutical analytics?

Yes, Allot is integrating generative AI into its commercial pharma services, as noted in company blogs. This includes enhancing data analysis and strategy tools, though specific AI applications beyond existing Pharlytics® and RankX© functionalities aren't detailed publicly. (45 words)

How does Allot support sustainability in pharma?

Allot offers ESG and NetZero initiatives through dedicated sustainability services. These help pharmaceutical clients align commercial strategies with environmental goals, though the company hasn't disclosed detailed methodologies or case studies about these offerings. (42 words)

What challenges does Allot face in pharma analytics?

Allot competes with larger analytics firms while depending heavily on NHS policy stability. Data privacy regulations and scaling AI/sustainability services present additional hurdles in this specialized market where pharma clients demand both innovation and compliance. (45 words)

Sources

  1. www.allotltd.com — Product descriptions for Pharlytics® and RankX©
  2. www.allotltd.com — Company focus on generative AI and sustainability services
  3. www.allotltd.com — Company’s ESG and NetZero initiatives
  4. www.allotltd.com — Focus on commercial pharma and NHS guidance